Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shepherd's purse (Capsella bursa-pastoris) is a medicinal plant in the Brassicaceae family recognized for its hemostatic, anti-inflammatory, and antimicrobial properties. It contains various bioactive compounds, including flavonoids, sulfur glycosides (bursapastoris A-B), and the antimicrobial peptide Shepherin I. Clinical research has evaluated its efficacy in herbal vagitories for treating non-specific vaginitis, where it demonstrated improvements in both subjective and objective symptoms. Additionally, it is studied for its potential to control severe hemorrhagic wounds through incorporation into hydrogel-based dressings and for its ability to mitigate liver injury by regulating glucolipid metabolism and the NF-κB signaling pathway. Caution is advised regarding its use alongside anticoagulants like warfarin due to potential drug-herb interactions that may increase bleeding risks.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on shepherd's purse.